This work demonstrates the critical role of SK4 Ca2+‐activated K+ channels in adult pacemaker function, making them promising therapeutic targets for the treatment of cardiac ventricular arrhythmias such as CPVT. Here, KCNN4 is linked to catecholaminergic polymorphic ventricular tachycardia.